Efficacy of Lazolex® Gel in the Treatment of Herpes Simplex Mucocutaneous Infections and the Prevention of Recurrences: A Pilot Study

Table 1

Visit schedule and assessed data during the trial.

Examination day	Screening period	Treatment period				Follow-up period
	Day 0	Day 1	Day 5	Day 10	Day 20	Subsequent 4 years
General information
Age, sex	X
Written informed consent signed	X
Case history including frequency of outbreaks prior to study	X
Objective assessment
General physical examination	X	X	X	X	X
Laboratory tests	X			X
Assessment of tolerance				X	X
Assessment of efficacy				X	X	X
Characteristics of HSV lesion
Affected area (cm^2)	X	X	X	X	X
Lesion stage	X	X	X	X	X
Occurring symptoms (itching, pain, burning)	X	X	X	X	X
Photo documentation	X	X	X	X
Subjective assessment
Reporting of side effects		X	X	X	X
Degree of satisfaction with treatment						X

HSV: Herpes simplex virus.